Levodopa FDA Link Generic

The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.

Also Known As:

L Dopa; Larodopa; 3-Hydroxy-L-tyrosine; Dopaflex; Dopar; L-3,4-Dihydroxyphenylalanine; Levopa; 3 Hydroxy L tyrosine; L 3,4 Dihydroxyphenylalanine; L-Dopa

Pharmalogical Action Categories:

Antiparkinson Agents
Dopamine Agents

Organic Chemicals: 133
- Amines: 4871
  - Catecholamines: 15682
    - Dihydroxyphenylalanine: 1494
      - Levodopa: 12762
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Catecholamines: 15682
        Dihydroxyphenylalanine: 1494
        Levodopa: 12762
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Tyrosine: 10509
        Dihydroxyphenylalanine: 1494
        Levodopa: 12762
      - Phenylalanine: 4090
        Dihydroxyphenylalanine: 1494
        Levodopa: 12762

Catherine Auxiette Selected Research

Catherine Auxiette Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure